A blood-based, cell-free deoxyribonucleic acid (cfDNA) fragmentome assay for lung cancer detection.
How next-gen sequencing is changing antibody drug discovery
New study outlines how next-generation sequencing (NGS) and machine-learning methods can revolutionize antibody discovery, particularly against SARS-CoV-2. The research demonstrates that NGS provides greater epitopic
October 31, 2023